PubMed · 2010 · 62 citations · 13 references
Life SciencesBiochemistryOncologyCellular MetabolismMetabolismMolecular OncologyCancer Cell SignalingCancer MetabolismEnzyme InhibitionGlycolysis RegulationMetabolic Reprogramming In CancerPancreatic CancerGlycolysis In Cancer MetabolismGlycolytic SignalingMetabolic Pathway InhibitionTumor MetabolismWestern Blot Analysis
BACKGROUND AND AIM: The importance of glycolysis in cancer cells is well documented. The effects of inhibiting glycolysis using metabolic inhibitors iodoacetate (IAA), an inhibitor of GAPDHase, and 3-bromopyruvate (3BP), an inhibitor of hexokinase-II, on survival and signaling of pancreatic cancer cells (Panc-1) were investigated. MATERIALS AND METHODS: Cellular survival was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Lactate dehydrogenase (LDH) assay was used to analyze the induced necrosis and protein levels were evaluated using Western blot analysis. RESULTS: The results show that the inhibitors lowered cellular survival and increased cellular necrosis. Mitogenic signaling pathways were affected by 3BP but not by IAA. CONCLUSION: We conclude that there may be a cross-talk between signaling pathways and glycolysis in regulating pancreatic cancer cell survival and signaling. Thus, a combination of agents that inhibit both energy production and cell signaling may provide a novel and effective approach to target pancreatic cancer effectively.
13
American Association of Industrial Nurses Journal · 1968 · 8.9K citations
Akt Stimulates Aerobic Glycolysis in Cancer Cells
Rebecca Elstrom, Daniel E. Bauer, Monica Buzzai et al. · Cancer Research · 2004 · 1.5K citations
Medicine, Cancer Biology, Oncology +17
J.F. Geschwind, Young Hee Ko, Michael Torbenson et al. · PubMed · 2002 · 257 citations
Medicine, Oncology, Pharmacology +16